vs
AVIAT NETWORKS, INC.（AVNW）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
AVIAT NETWORKS, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍（$111.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.1%，领先378.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -5.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.3%）
Aviat Networks是全球领先的微波传输与回传解决方案供应商，为公共及私营通信运营商提供通信基础设施支撑，同时也面向企业客户提供相关产品与服务，助力客户构建稳定高效的通信网络。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AVNW vs RIGL — 直观对比
营收规模更大
AVNW
是对方的1.6倍
$69.8M
营收增速更快
RIGL
高出26.9%
-5.7%
净利率更高
RIGL
高出378.9%
5.1%
两年增速更快
RIGL
近两年复合增速
0.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $111.5M | $69.8M |
| 净利润 | $5.7M | $268.1M |
| 毛利率 | 32.4% | 91.5% |
| 营业利润率 | 6.5% | 33.2% |
| 净利率 | 5.1% | 384.0% |
| 营收同比 | -5.7% | 21.2% |
| 净利润同比 | 27.2% | 1769.2% |
| 每股收益（稀释后） | $0.44 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNWRIGL
| Q4 25 | $111.5M | $69.8M | ||
| Q3 25 | $107.3M | $69.5M | ||
| Q2 25 | $115.3M | $101.7M | ||
| Q1 25 | $112.6M | $53.3M | ||
| Q4 24 | $118.2M | $57.6M | ||
| Q3 24 | $88.4M | $55.3M | ||
| Q2 24 | $116.7M | $36.8M | ||
| Q1 24 | $110.8M | $29.5M |
净利润AVNWRIGL
| Q4 25 | $5.7M | $268.1M | ||
| Q3 25 | $162.0K | $27.9M | ||
| Q2 25 | $5.2M | $59.6M | ||
| Q1 25 | $3.5M | $11.4M | ||
| Q4 24 | $4.5M | $14.3M | ||
| Q3 24 | $-11.9M | $12.4M | ||
| Q2 24 | $1.5M | $-1.0M | ||
| Q1 24 | $3.9M | $-8.2M |
毛利率AVNWRIGL
| Q4 25 | 32.4% | 91.5% | ||
| Q3 25 | 33.2% | 93.2% | ||
| Q2 25 | 34.2% | 95.6% | ||
| Q1 25 | 34.9% | 91.7% | ||
| Q4 24 | 34.6% | 89.9% | ||
| Q3 24 | 22.4% | 85.5% | ||
| Q2 24 | 35.3% | 92.4% | ||
| Q1 24 | 32.5% | 93.1% |
营业利润率AVNWRIGL
| Q4 25 | 6.5% | 33.2% | ||
| Q3 25 | 4.8% | 40.9% | ||
| Q2 25 | 7.7% | 60.1% | ||
| Q1 25 | 8.3% | 23.9% | ||
| Q4 24 | 6.7% | 28.9% | ||
| Q3 24 | -17.6% | 25.4% | ||
| Q2 24 | 4.7% | 1.2% | ||
| Q1 24 | 5.1% | -23.6% |
净利率AVNWRIGL
| Q4 25 | 5.1% | 384.0% | ||
| Q3 25 | 0.2% | 40.2% | ||
| Q2 25 | 4.5% | 58.6% | ||
| Q1 25 | 3.1% | 21.5% | ||
| Q4 24 | 3.8% | 24.9% | ||
| Q3 24 | -13.4% | 22.5% | ||
| Q2 24 | 1.3% | -2.8% | ||
| Q1 24 | 3.5% | -27.9% |
每股收益（稀释后）AVNWRIGL
| Q4 25 | $0.44 | $14.11 | ||
| Q3 25 | $0.01 | $1.46 | ||
| Q2 25 | $0.42 | $3.28 | ||
| Q1 25 | $0.27 | $0.63 | ||
| Q4 24 | $0.35 | $0.82 | ||
| Q3 24 | $-0.94 | $0.70 | ||
| Q2 24 | $0.11 | $-0.06 | ||
| Q1 24 | $0.30 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $86.5M | $155.0M |
| 总债务越低越好 | $105.4M | $52.5M |
| 股东权益账面价值 | $271.6M | $391.5M |
| 总资产 | $659.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.39× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AVNWRIGL
| Q4 25 | $86.5M | $155.0M | ||
| Q3 25 | $64.8M | $137.1M | ||
| Q2 25 | $59.7M | $108.4M | ||
| Q1 25 | $49.4M | $77.1M | ||
| Q4 24 | $52.6M | $77.3M | ||
| Q3 24 | $51.0M | $61.1M | ||
| Q2 24 | $64.6M | $49.1M | ||
| Q1 24 | $59.2M | $49.5M |
总债务AVNWRIGL
| Q4 25 | $105.4M | $52.5M | ||
| Q3 25 | $106.5M | $60.0M | ||
| Q2 25 | $87.6M | $60.0M | ||
| Q1 25 | $73.9M | $60.0M | ||
| Q4 24 | $74.9M | $60.0M | ||
| Q3 24 | $83.4M | $60.0M | ||
| Q2 24 | $48.4M | $60.0M | ||
| Q1 24 | $48.9M | $60.0M |
股东权益AVNWRIGL
| Q4 25 | $271.6M | $391.5M | ||
| Q3 25 | $263.6M | $117.6M | ||
| Q2 25 | $263.2M | $81.9M | ||
| Q1 25 | $256.1M | $18.6M | ||
| Q4 24 | $249.6M | $3.3M | ||
| Q3 24 | $247.1M | $-14.6M | ||
| Q2 24 | $255.9M | $-29.9M | ||
| Q1 24 | $256.0M | $-31.7M |
总资产AVNWRIGL
| Q4 25 | $659.4M | $513.6M | ||
| Q3 25 | $643.3M | $242.5M | ||
| Q2 25 | $633.3M | $206.7M | ||
| Q1 25 | $628.3M | $176.0M | ||
| Q4 24 | $594.1M | $164.0M | ||
| Q3 24 | $590.9M | $139.4M | ||
| Q2 24 | $535.2M | $128.4M | ||
| Q1 24 | $490.3M | $126.5M |
负债/权益比AVNWRIGL
| Q4 25 | 0.39× | 0.13× | ||
| Q3 25 | 0.40× | 0.51× | ||
| Q2 25 | 0.33× | 0.73× | ||
| Q1 25 | 0.29× | 3.23× | ||
| Q4 24 | 0.30× | 18.25× | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $22.5M | — |
| 自由现金流率自由现金流/营收 | 20.2% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 4.18× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $16.1M | — |
8季度趋势，按日历期对齐
经营现金流AVNWRIGL
| Q4 25 | $23.9M | $22.0M | ||
| Q3 25 | $-11.7M | $24.0M | ||
| Q2 25 | $10.5M | $30.5M | ||
| Q1 25 | $1.6M | $-893.0K | ||
| Q4 24 | $20.8M | $14.5M | ||
| Q3 24 | $-27.2M | $21.7M | ||
| Q2 24 | $8.3M | $302.0K | ||
| Q1 24 | $15.3M | $-5.0M |
自由现金流AVNWRIGL
| Q4 25 | $22.5M | — | ||
| Q3 25 | $-13.5M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $18.3M | — | ||
| Q3 24 | $-32.6M | — | ||
| Q2 24 | $7.5M | — | ||
| Q1 24 | $14.8M | — |
自由现金流率AVNWRIGL
| Q4 25 | 20.2% | — | ||
| Q3 25 | -12.6% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | -1.0% | — | ||
| Q4 24 | 15.5% | — | ||
| Q3 24 | -36.8% | — | ||
| Q2 24 | 6.4% | — | ||
| Q1 24 | 13.4% | — |
资本支出强度AVNWRIGL
| Q4 25 | 1.3% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 6.1% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.4% | — |
现金转化率AVNWRIGL
| Q4 25 | 4.18× | 0.08× | ||
| Q3 25 | -72.48× | 0.86× | ||
| Q2 25 | 2.02× | 0.51× | ||
| Q1 25 | 0.46× | -0.08× | ||
| Q4 24 | 4.62× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
RIGL
暂无分部数据
